Dr. Brent G. Kobashi, MD

Dr. Kobashi practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Kobashi's NPI, 1780851899, was assigned on May 8, 2008. Dr. Kobashi graduated from Stanford University School Of Medicine in 2006. Dr. Kobashi's California license number on file is A103699.

Dr. Kobashi's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Kobashi's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Kobashi to 4 more group practices and clinics, 4 medical groups and 2 home health agencies, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kobashi practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Kobashi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Kobashi is board certified in internal medicine by the American Board of Internal Medicine. Dr. Kobashi has a license on file in California.

Dmand AI lists acid reflux, acute skin infection, adjustment disease, anxiety, asthma, chest wall injury, chronic anemia and chronic diabetes among the conditions Dr. Kobashi treats.

CMS data shows 852 Medicare services from Dr. Kobashi across 5 procedure codes in 2024, for 254 Medicare patients. Medicare paid $43,501 for them.

CMS counts 254 Medicare patients who saw Dr. Kobashi in 2024. The largest group is 75 to 84, with 108 patients. 69% of them have high cholesterol, and 68% have high blood pressure. 35% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kobashi's median patient age at 68, with 43% women.

In 2024, Dr. Kobashi wrote 3,186 Medicare Part D claims for 292 patients. 88% of them were for generic drugs. CMS names the drug for 2,564 of them, across 55 drugs with 11 or more claims each, at $128,316 in total drug cost. In 2023, CMS named 1,645 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Kobashi for performance year 2024, reported as part of a group. Dr. Kobashi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kobashi as offering telehealth.

Dmand AI links 3 papers to Dr. Kobashi in 2015. 2015 was the busiest year, with 3. Dr. Kobashi's most frequent co-authors are Shannon Elizabeth Fogh, MD and Patricia O'Sullivan, MD.

Dmand AI lists 2 awards for Dr. Kobashi, most recently NCQA PCMH in 2016.

Dr. Kobashi graduated from Stanford University School Of Medicine in 2006.

Dr. Kobashi is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.